SCHEMBL19202355

SCHEMBL19202355

COC(=O)c1cc(Br)ccc1S(N)(=O)=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.61
CA1 P00915 6/20 0.61
CA9 Q16790 6/20 0.61
CA5A P35218 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.47
NR4A2 P43354 1/20 0.47
CDK1 P06493 1/20 0.47
GAA P10253 2/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
CA12 O43570 5/20 0.43
HSD17B10 Q99714 1/20 0.43
SLC6A3 Q01959 1/20 0.42
CA7 P43166 2/20 0.41
CA14 Q9ULX7 2/20 0.41
PDK2 Q15119 1/20 0.41
PDK4 Q16654 1/20 0.41
CES2 O00748 1/20 0.41
GALR3 O60755 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962894 0.87 CA2 (0.61) CA2CA1CA9CA5AL3MBTL1
SCHEMBL424814 0.85 L3MBTL1 (0.48) CA2CA1CA9CA5AL3MBTL1
SCHEMBL30546511 0.85 L3MBTL1 (0.48) CA2CA1CA9CA5AL3MBTL1
SCHEMBL1557539 0.84 L3MBTL1 (0.47) CA2CA1CA9CA5AL3MBTL1
SCHEMBL22827685 0.83 MAPT (0.46) CA2CA1CA9CA5AL3MBTL1
SCHEMBL21962910 0.82 CA2 (0.63) CA2CA1CA9CA5ACDK1
SCHEMBL11226378 0.82 CA2 (0.63) CA2CA1CA9CA5ACDK1
SCHEMBL30827404 0.82 CA2 (0.63) CA2CA1CA9CA5ACDK1
SCHEMBL22827959 0.81 CA2 (0.61) CA2CA1CA9CA5ANR4A2
SCHEMBL9143218 0.81 CA2 (0.61) CA2CA1CA9CA5ACDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020254697-A1 FUSED 1,2 THIAZOLES AND 1,2 THIAZINES WHICH ACT AS NL3P3 MODULATORS AC IMMUNE SA (CH) 2020-12-24 WO disclosed
CN-108164521-B Parecoxib sodium degradation impurity, and preparation method, detection method and application thereof 成都新恒创药业有限公司 2020-11-13 CN disclosed
WO-2017128896-A1 FXR AGONIST AND PREPARATION METHOD AND USE THEREOF 江苏豪森药业集团有限公司 2017-08-03 WO disclosed